597: Expert insights on hormone replacement therapy for women

“HRT is probably the best thing that you can do to improve long term health and longevity,” explains Amy Killen, M.D. In this episode, we’re covering everything you need to know about hormone replacement therapy, including the incredible benefits of HRT and when you should consider starting HRT.  You’ll hear from: Maddy Dychtwald, author, longevity expert, and co-founder of Age Wave, on the study that changed the way HRT was viewed and why it’s time to rethink that narrative  Marty Makay, M.D., the US Commissioner of Food and Drugs, a Johns Hopkins surgeon, public health expert, on why hormone replacement therapy may be one of the most powerful tools for women  Amy Killen, M.D., a longevity and regenerative medicine physician, on when to consider HRT and how it supports long-term health Jessica Shepherd, M.D., OB/GYN and menopause expert, on the different types of hormone therapy and how to find a provider who supports your goals We’ll cover: - The flawed study that changed HRT perception (~1:05) - The incredible benefits of HRT (~4:15) - What about TRT for men? (~7:20) - Hormone health is longevity (~8:45) - When to consider HRT (~9:48) - The different types of HRT (~11:10) - You are the CEO of your health (~13:48) Listen to the full episodes here:  - Why women live longer, but not better | Longevity expert Maddy Dychtwald - The most common health myths, debunked | Marty Makary, M.D. - Stem cells, HRT, & nitric oxide for women | Amy Killen, M.D. - What women need to know about hormone replacement therapy (HRT) | Jessica Shepherd, M.D. Thanks for listening to this special episode—brought to you by ⁠Solaray⁠, the #1 vitamin and mineral supplement brand in health food stores. Try their SharpMind formulas today at 30% off. Visit Solaray.com and use code MINDBODYGREEN. Be Sharper. Live Brighter. Discount Code: MINDBODYGREEN Visit ⁠https://solaray.com/sharpmind ⁠for 30% off Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.